Q3 2025 Earnings Call Transcript October 28, 2025 Labcorp Holdings Inc. beats earnings expectations. Reported EPS is $4.18, ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) in Q3 CY2025, with sales up 8.6% year on year to $3.56 billion. Its ...

Guidance Updates -- Full-year 2025 revenue growth guidance was narrowed to 7.4%-8%, with Adjusted EPS guidance was set at $16 ...

Labcorp has launched the first blood-based in-vitro diagnostic test cleared by the Food and Drug Administration to aid in the diagnosis of Alzheimer's disease. The test--called the Lumipulse ...

Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive ...

NEW YORK – With its new Test Finder software tool developed in collaboration with Amazon Web Services (AWS), Laboratory Corporation of America aims to streamline test ordering for clinicians. Launched ...

Diagnostics giant Labcorp has introduced Test Finder, a generative AI tool developed in conjunction with Amazon Web Services (AWS). Test Finder aims to simplify lab test selection by permitting ...

Labcorp Holdings made significant advancements with the launch of its Test Finder tool, developed in collaboration with Amazon Web Services, aimed at enhancing lab test selection for healthcare ...

Laboratory testing plays a critical role in healthcare, informing nearly 70% of clinical decisions and often serving as the first step in diagnosing and managing patient conditions. Yet research shows ...

(RTTNews) - Labcorp (LH) announced the expansion of its precision oncology portfolio. The additions include new test offerings for solid tumor and hematologic malignancies and enhanced biopharma ...

Association of complementing circulating tumor DNA and circulating tumor cells load on stable and progressive disease in treated patients. Development, comparative study, and external validation of a ...